Association between serum GDF-15 and hypertension in the third trimester of pregnancy

Cheng Chen1, Qin Li1, Yanxiang Wang2

  • 1Department of Medical Science, Yangzhou Polytechnic College, Yangzhou, Jiangsu Province, China.

Insights

Serum Growth Differentiation Factor 15 (GDF-15) was elevated in pregnant women with hypertensive disorders of pregnancy (HDP). Higher GDF-15 levels correlated with increased blood pressure in these patients.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Health
  • Biomarkers in Pregnancy

Background:

  • Hypertensive disorders of pregnancy (HDP) pose significant risks to maternal and fetal health.
  • Understanding the underlying pathophysiology of HDP is crucial for improved management.
  • Growth Differentiation Factor 15 (GDF-15) is a cytokine with potential roles in inflammatory and stress responses.

Purpose of the Study:

  • To investigate serum Growth Differentiation Factor 15 (GDF-15) expression in third-trimester pregnant women with HDP.
  • To examine the correlation between serum GDF-15 levels and blood pressure parameters (systolic and diastolic) in women with HDP.

Main Methods:

  • A cross-sectional study design was employed.
  • Participants included 60 third-trimester pregnant women diagnosed with HDP and 50 healthy pregnant controls.
  • Serum GDF-15 levels were quantified, and clinical characteristics were recorded.

Main Results:

  • Serum GDF-15 levels were significantly higher in the HDP group compared to the control group.
  • A positive correlation was observed between serum GDF-15 levels and both systolic and diastolic blood pressure in women with HDP.

Conclusions:

  • Elevated serum GDF-15 may serve as a potential biomarker in hypertensive disorders of pregnancy.
  • GDF-15 levels appear to be associated with the severity of HDP, particularly concerning blood pressure elevation.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
471
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
743
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
795
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K